5-alpha reductase inhibitors clinical trials
A class of medicines: the studies that test any of its 2 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones. In MeSH: 5-alpha Reductase Inhibitors.
Get an email when these change. Save the 5-alpha reductase inhibitors studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Medicines in this class
Studies that test each. A study of two counts under both, and once above.
Studies by the year they started
119 studies that test it; most in 2006 (13); 1 more planned to start later
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1998 | 1 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 11 |
| 2005 | 7 |
| 2006 | 13 |
| 2007 | 9 |
| 2008 | 10 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 43 · Other 77
GlaxoSmithKline (22) · University of Washington (7) · UConn Health (5) · VA Office of Research and Development (4) · Dr. Reddy's Laboratories Limited (4) · National Eye Institute (NEI) (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Beth Israel Deaconess Medical Center (2)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing one of them · 120
- Perioperative Dutasteride for Hemorrhage Control in Bipolar TURP Under Anticoagulation.Not yet recruitingPhase 4Mohamed Mahmoud DoghaNCT07911501Written as Dutasteride (0.5mg)
- Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic HyperplasiaNot yet recruitingPhase 3Il-Yang Pharm. Co., Ltd.NCT07870759Written as Finasteride 5 mg Tablet, single dose
- Sleep Apnea in ElderlyRecruitingPhase 4VA Office of Research and DevelopmentNCT02703220Written as Finasteride
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingPhase 2/3VA Office of Research and DevelopmentNCT07742553Written as finasteride
- Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder CancerRecruitingPhase 2Paul TorenNCT07420517Written as Dutasteride (0.5mg)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)Not yet recruitingNot applicableAssiut UniversityNCT07421804Written as topical dutasteride
- Phase II Dutasteride in Combination With CAB vs CAB in SDCRecruitingPhase 2Radboud University Medical CenterNCT05513365Written as Dutasteride 0.5 mg
- Various Procedural Treatment Options for Androgenetic AlopeciaNot yet recruitingPhase 2Sheikh Zayed Medical CollegeNCT06826001Written as topical finasteride
- Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic AlopeciaRecruitingPhase 2/3Indonesia UniversityNCT05990400Written as Finasteride
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyActive, not recruitingNot applicableBeth Israel Deaconess Medical CenterNCT04288427Written as Finasteride
- REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenActive, not recruitingNot applicableBoston Scientific CorporationNCT04838769Written as alpha blocker and 5-alpha reductase inhibitor
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaCompletedPhase 2Beijing Dayspring Pharmaceutical Technology Co., LtdNCT07076706Written as minoxidil + finasteride
- Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.CompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT07322991Written as IY001(Finasteride)
- Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its ProgressionActive, not recruitingNot applicableCHU de Quebec-Universite LavalNCT01653925Written as Drug (Dutasteride) intervention first
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerActive, not recruitingNot applicableUniversity of ChicagoNCT01342367Written as Dutasteride
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of EfficacyCompletedPhase 2/3UConn HealthNCT04098302Written as Dutasteride Capsules
- Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.CompletedPhase 2Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalNCT05599243Written as Dutasteride
- Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.CompletedPhase 2/3Ente Ospedaliero Ospedali GallieraNCT06601205Written as Finasteride
- Finasteride 5 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00835666Written as Finasteride 5 mg tablets
- Finasteride 5 mg Tablets, Non-fastingCompletedPhase 1Teva Pharmaceuticals USANCT00835796Written as Finasteride 5 mg tablets
See all 120 studies that test one of the 5-alpha reductase inhibitors →
Codes
What other systems call 5-alpha reductase inhibitors · ClinicalTrials.gg INT008931
- MeSH (NLM) D0588915-alpha Reductase InhibitorsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D058891 | 5-alpha Reductase Inhibitors | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.